Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure?

Diabetes Obes Metab. 2021 Sep;23(9):2194-2196. doi: 10.1111/dom.14444. Epub 2021 Jun 9.

Authors

Irene Caruso¹, Angelo Cignarelli¹, Luigi Laviola¹, Francesco Giorgino¹

Affiliation

¹ Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.

PMID: 34033214
DOI: 10.1111/dom.14444

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Glucose
Heart Failure* / prevention & control
Humans
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Symporters*

Substances

Sodium-Glucose Transporter 2 Inhibitors
Symporters
Sodium
Glucose